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Abstract
Background: The transcription factor Yin Yang 2 (YY2) shares a structural and functional highly
homologue DNA-binding domain with the ubiquitously expressed YY1 protein, which has been
implicated in regulating fundamental biological processes. However, the biological relevance of YY2
has not been identified yet.
Results: Towards the understanding of YY2 biology, we analyzed in detail the expression pattern
of  yy2 in various organs during embryonic and postnatal mouse development till adulthood.
Thereby, a constant yy2 level was detected in heart and lung tissue, whereas in different brain
regions yy2 expression was dynamically regulated. Interestingly, in any analyzed tissue neither the
homologue yy1 nor the mbtps2 gene showed changes in mRNA expression levels like yy2, although
the intronless yy2 gene is located within the mbtps2 locus.
Furthermore, we detected yy1, yy2, and mbtps2 mRNA in primary mouse neurons, microglia cells,
and astrocytes. In comparison to yy2 and mbtps2, yy1 revealed the highest expression level in all
cell types. Again, only yy2 showed significantly altered gene expression levels among the cell types.
Higher yy2 expression levels were detected in microglia cells and astrocytes than in primary
neurons.
Conclusion:  Yy2 expression in the heart and lung is constitutively expressed during
embryogenesis and in adult mice. For the first time, developmental changes of yy2 transcription
became obvious in various areas of the brain. This suggests that yy2 is involved in developmental
gene regulation.
Background
The biology of the transcription factor Yin Yang 2 (YY2) is
not well characterized yet, but may be of particular inter-
est due to its similarities to the ubiquitously expressed
YY1, which has been implicated in fundamental biologi-
cal processes such as DNA-replication, cell cycle regula-
tion and organogenesis [1-5]. YY2 is a zinc finger protein
that shares 56% sequence homology with YY1 [6]. Espe-
cially, the C-terminal DNA-binding zinc finger is highly
conserved [6-8] and mediates a similar binding specificity
to the 5'-(A/c/g)(A/t)NATG(G/a/t)(C/a)(G/c/t)-3' DNA
consensus motif [8,9], suggesting synergistic or competi-
tive functions, if both factors act within the same cell [10].
The biological significance of yy1 is highlighted by early
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embryonic lethality of mice with homozygous yy1 dele-
tion. In addition, mice with heterozygous yy1 ablation
show growth retardation and defects in neurulation [3].
Analysis of yy2 ablation has not been reported, yet. The
intron lacking yy2  gene is extraordinarily positioned
between exons 5 and 6 of another X-chromosomally
located gene encoding mbtps2 (membrane bound tran-
scription factor protease site 2). First expression analyses
by in situ hybridization in testis, ovaries and brain from
adult mice suggested a shared control of yy2 and mbtps2
gene activities [7]. However, our data indicate that the
upstream region of the human YY2 gene mediates signifi-
cant promoter activity independently from MBTPS2 [11].
To gain more information on the biology of yy2, we estab-
lished whole mount in situ hybridization. In parallel, real-
time PCR was used to quantify yy2 mRNA expression in
various organs of developing and adult mice more pre-
cisely. Herein, we demonstrate that the yy2 mRNA expres-
sion pattern differs from that of yy1  and  mbtsp2.
Importantly, yy2 expression underlies significant changes
during development, particularly in various areas of the
brain.
Results
Expression of yy2 in mouse embryos
Since there are only limited data available on the organ-
specific yy2  expression [6,7], we established the whole
mount in situ hybridization technique. First experiments
with DIG-labeled riboprobes showed wide spread signals
of yy2 transcripts on the entire E11.5 embryo (Figure 1A),
suggesting ubiquitous expression similar as described for
yy1 [3]. The specificity of the antisense riboprobe staining
is underlined by the negative control, where the embryo
was incubated with the corresponding sense riboprobe
(Figure 1B). To analyze the yy2 expression pattern more
precisely, we subsequently performed TaqMan real-time
PCR in selected organs and tissue specimens of develop-
ing and adult mice.
Quantitative analysis of yy2 expression in heart and lung
Specimens of the heart and lung, taken at several develop-
mental stages, were dissected, and cDNAs were amplified
out of isolated RNA. We analyzed samples spanning from
E14 to P60, since in earlier developmental stage region-
specific specimens cannot be isolated due to technical
limitations. By using TaqMan real-time PCR technique
with FAM-labeled probes, we tested the specimens also for
yy1  and  mbtps2  transcripts. For all three transcripts we
found almost stable expression level throughout all tested
developmental stages of the heart (Figure 2) and lung
(Figure 3). However, in contrast to the highly expressed
yy1, the amount of yy2 and mbtps2 transcripts was clearly
lower in all developmental stages. Interestingly, yy2 and
mbtps2 showed always similar expression levels. Thus, nei-
ther the yy  genes nor mbtps2  showed any significant
changes in expression during heart and lung develop-
ment.
Quantitative analysis of yy2 expression in the brain
Previously, the expression of yy2, yy1 and mbtps2 in the
neocortex and cerebellum of adult mice has been shown
by in situ hybridization, but not quantified [7]. To analyze
the gene expression during development we used the
quantitative real-time PCR technique. As shown in Figure
Expression of yy2 in developing mice Figure 1
Expression of yy2 in developing mice. A. Whole mount 
in situ hybridization of E11.5 embryo with a DIG-labeled yy2 
antisense riboprobe. For a better orientation different 
regions are indicated; forebrain (fb), midbrain (mb), hindbrain 
(hb), optical vesicles (op), spinal cord (sc), forelimb buds (fl), 
liver (li) and hindlimb buds (hl). B. Hybridization with the yy2 
sense riboprobe served as control (magnification: 4-fold).
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Quantification of yy2, mbtps2 and yy1 in developing heart Figure 2
Quantification of yy2, mbtps2 and yy1 in developing 
heart. Expression levels of yy2, mbtps2 and yy1 transcripts in 
the heart during development and in adult mice (E14 to P30) 
quantified by TaqMan real-time PCR. The expression is nor-
malized to β-actin. All three gene products are constitutively 
expressed at constant levels throughout all stages. (n = 3 
sets).
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4 and 5, there were significant changes of yy2 expression
from day E14 to P60 by means of TaqMan real-time PCR.
By contrast, the yy1 levels remained stable. Interestingly,
in cerebellum the amount of yy2 increased up to 6-fold
with maturation. In the neocortex yy2 expression signifi-
cantly decreased during intrauterine gestation, reached a
minimum in the early neonatal period, before it increased
again in adult mice (P60). However, the content of yy2
transcripts in the hippocampus remained stable on a
lower level compared to those of cerebellum and neocor-
tex (Figure 6). In all brain regions, mbtps2 and yy1 were
consistently higher expressed (up to 10-fold) than yy2. In
contrast to yy2, transcripts of yy1 and mbtps2 were almost
constitutively expressed during development. The com-
bined data indicate that yy2 expression underlies a tissue-
and developmental-stage specific regulation.
Quantification of yy2, mbtps2 and yy1 in developing lung Figure 3
Quantification of yy2, mbtps2 and yy1 in developing 
lung. Quantification of yy2, mbtps2 and yy1 transcripts levels 
in the lung during embryogenesis and adult stages (E14 to 
P30) by TaqMan real-time PCR. The expression data are nor-
malized to β-actin. The pattern is similar to the heart ana-
lyzes. (n = 3 sets).
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Quantification of yy2, mbtps2 and yy1 in developing cerebel- lum Figure 4
Quantification of yy2, mbtps2 and yy1 in developing 
cerebellum. Analyzes of yy2, mbtps2 and yy1 expression in 
the cerebellum throughout development (E14 to P60). Taq-
Man real-time PCR revealed that mbtps2 and yy1 are consti-
tutively expressed at almost constant levels, whereas yy2 
expression is low at E14, but increases significantly until P60. 
Expression levels are normalized to β-actin. (n = 3 sets; * p < 
0.05; ** p < 0.01; statistical significances refer to E14).
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Quantification of yy2, mbtps2 and yy1 in developing neocor- tex Figure 5
Quantification of yy2, mbtps2 and yy1 in developing 
neocortex. Quantitative expression analyses (TaqMan real-
time PCR) of yy2, mbtps2 and yy1 transcripts in the neocor-
tex during development and in adult mice (E14 to P60). The 
expression of yy2 reaches a minimum around day P5. Expres-
sion levels are normalized to β-actin. (n = 3 sets; * p < 0.05; 
** p < 0.01; statistical significances refer to E14).
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Quantification of yy2, mbtps2 and yy1 in developing hippoc- ampus Figure 6
Quantification of yy2, mbtps2 and yy1 in developing 
hippocampus. Expression levels of yy2, mbtps2 and yy1 
transcripts in the hippocampus during development and in 
adult mice (E14 to P30) quantified by TaqMan real-time PCR. 
The expression is normalized to β-actin. All three gene prod-
ucts are constitutively expressed at constant levels through-
out all stages. (n = 3 sets).
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Quantitative analysis of yy2 expression in neurons, 
astrocytes and microglia
Due to the dynamic regulation of yy2 expression in neo-
cortex and cerebellum, we analyzed the expression of yy2,
yy1 and mbtps2 transcript levels in primary neurons, astro-
cytes and microglia of mice by using real-time PCR. As
depicted in Figure 7, yy1 was strongly expressed at similar
levels within all three cell types, whereas yy2 and mbtps2
were found at lower levels. Especially neurons contained
a very low amount of yy2 transcript, if compared to astro-
cytes and microglia cells [see also additional file 1].
Discussion
Herein, for the first time we provide data implying that
the transcription factor yy2 possess a functional role dur-
ing development, as it has already been shown for its
famous and well characterized homologue yy1 [3,12,13].
Since, yy2 is broadly, possibly ubiquitously expressed in
embryonic mice (Figure 1), we conducted extensive real-
time PCR analyses indicating a tissue-specific expression
pattern that is in part developmentally regulated. Thereby,
our experiments were especially focused on the cardiopul-
monary and central nervous system.
Expression of yy1, yy2 and mbtps2 could be detected in all
analyzed organs, tissues and cells [see also additional file
2]. While their expression levels did not change signifi-
cantly during development of heart and lung, the speci-
mens from the brain revealed a more dynamic expression
pattern. The relative high amount of yy1 transcripts in the
cerebellum, neocortex and hippocampus underlines the
broad implication of yy1 in the brain at all stages of mice
development [14]. In fact, its functional role in the nerv-
ous system has been demonstrated by analyses of hetero-
zygous  yy1  knock-out mice [3,12] and conditional
ablation of yy1 in oligodendrocytes [15]. By contrast, the
amount of yy2 showed tissue-specific variations through-
out brain development (summarized in Figure 8). In the
cerebellum,  yy2  expression increased significantly from
early postnatal to adult. During this time period cerebel-
lum undergoes dramatic morphological changes, includ-
ing active neurogenesis, neuronal migration and
differentiation [16]. In cortical samples yy2  expression
revealed a u-shaped progression with a minimum starting
at birth. At this time point neurogenesis and neuronal
migration are completed in the cortex [17]. Here, it has to
be noted that cerebellum and cortex have specific parallel
neuronal connections between each other [18]. For exam-
ple, neurons from the motor cortex project to the cerebel-
lum. The hippocampus, however, involved in learning
and memory processes, exhibited a constant low level of
yy2 transcripts throughout development. Further analyses
of yy2 protein localization at the cellular level could help
to understand whether yy2 could be involved in control-
ling axon formation, migration, or dendritogenesis. This
issue cannot be examined so far, because currently no
appropriate antibody against murine yy2 is available.
By analyzing different primary cell types isolated from the
murine brain, we found differences of yy2 expression as
well, whereas yy1 levels showed no significant changes. In
contrast to microglia cells and astrocytes, neurons express
almost no yy2. The neuronal data suggest that yy2 could
be required for proliferation, since neurons, in contrast to
Quantification of yy2, mbtps2 and yy1 in primary cells Figure 7
Quantification of yy2, mbtps2 and yy1 in primary cells. 
Expression levels of yy2, mbtps2 and yy1 transcripts in the dif-
ferent primary cells (neurons, microglia and astrocytes) 
quantified by TaqMan real-time PCR. While mbtps2 and yy1 
are strongly and constantly expressed in all cell types, yy2 is 
significantly reduced in neurons. Expression values are nor-
malized to β-actin. (n = 3; ** p < 0.01).
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Comparison of yy2 expression in different brain regions Figure 8
Comparison of yy2 expression in different brain 
regions. Comparison of yy2 expression levels in the hippoc-
ampus, neocortex and cerebellum. E14 from cerebellum 
(lowest starting value) was defined as one. While expression 
of yy2 is stable in the hippocampus throughout all stages, the 
amount of yy2 transcripts varies significantly in cerebellum 
and neocortex. (n = 3 sets)
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astrocytes and microglia cells, cannot divide anymore.
Ongoing experiments may verify this hypothesis.
Comparing all real-time PCR results it becomes obvious
that the expression of yy2 and mbtps2, respectively, is indi-
vidually regulated depending upon the analyzed organ,
tissue or cell type. While both genes seem to be co-regu-
lated via the same promoter in heart and lung as well as in
microglia and astrocytes, however, the data from primary
neurons and all three brain tissues indicate an alternative
transcriptional activity. Currently, two different possibili-
ties of yy2 and mbtps2 gene regulation are discussed: (a)
both genes are under the control of the mbtps2 promoter,
and (b) yy2 transcription is mediated by its own adjacent
promoter, located upstream of its coding sequence, a
model that we favour according to own data on the regu-
lation of the human YY2 gene [7,11]. Of note, only the yy2
promoter shows a significant sensitivity against DNA-
(de)methylation, strengthening the implication of yy2 in
developmental processes. Our observations presented in
this manuscript emphasize that in fact both promoter
regions seem to be utilized in a tissue- or cell type-specific
manner.
Conclusion
The results from the real-time PCR experiments confirm
that yy2 is differentially expressed in the lung, heart and
brain, indicating a stringent spatial regulation and func-
tion. Precisely, we show a significant change of yy2 expres-
sion during the development and maturation of the
neocortex and cerebellum. Within the central nervous sys-
tem,  yy2  is predominantly expressed in astrocytes and
microglia cells.
Methods
Animals
C57/Bl6 mice were mated, and embryos/pups were col-
lected at defined time points (morning of vaginal plug
was considered as embryonic day E0.5). The protocol for
animal use was approved by the Institutional Review
Board (T 0167/08).
Preparation of primary neurons
Serum-free preparation of mouse cortical primary cultures
was performed with E18 (+/- 0.5 days) mouse embryos as
previously described [19]. After removal of meninges,
entire cortices were mechanically dissociated in HBSS
buffer (w/o Ca2+ and Mg2+), with trypsin (0.25%) for 10
min at 37°C. Trypsinization was stopped by adding min-
imum essential medium (Gibco-Invitrogen; Karlsruhe,
Germany). Medium was supplemented with 0.6% glu-
cose, 10% horse serum (Gibco), and penicillin and strep-
tomycin. Further mechanical dissociation was performed
by adding of DNAseI (0.06%). Cells were cultured on
poly-L-lysine-coated dishes at a density of 75.000 cells/
cm2. After three hours in vitro, medium was changed to
Neurobasal A medium (Gibco) supplemented with 2%
B27 (Gibco), 0.5 mM glutamine, and penicillin and strep-
tomycin for 12 days. Purity of neuronal cell preparation
was tested by real-time PCR [see additional file 3].
Preparation and purification of astrocytes and microglial 
cells
For astrocyte and microglia preparation, cerebra from
mouse pups aged P1 to P3 were prepared and the menin-
ges, including the pia mater and arachnoid, were carefully
removed and the cerebrum was washed in DMEM (4.5 g/
l glucose, 200 mM glutamine, pyrovate) containing 10%
fetal calf serum and 100 U/ml penicillin/streptomycin.
Following careful homogenization with a fire-polished
Pasteur pipette, a 10 min trypsin/DNAse (1.25%/2 U)
incubation followed, and digestion was stopped by add-
ing the same volume culture medium (DMEM containing
4.5 g/l glucose, 200 mM glutamine, pyrovate, 10% fetal
calf serum, and 100 U/ml penicillin/streptomycin). Dis-
sociated astrocytes were plated on poly-L-lysine (10 μg/
ml)-coated dishes. Every third day, dishes were shaken for
10 min at 37°C and afterwards rinsed three times with
warm PBS to remove microglial cells. They were then
resuspended with a fire-polished Pasteur pipette, and
replated in culture medium at low density. The suspended
microglial cells were collected and replated in astroglial
culture medium containing 2% fetal calf serum. Purity of
both cell types was tested by real-time PCR [see additional
file 3].
Whole-mount in situ expression analysis of yy2 mRNA
For in situ hybridization, a yy2 probe was generated by
cloning a yy2-specific 200 bp fragment (nt 11 to 200)
derived from the murine coding sequence [GenBank:
EF688658] into pBluescript SK (-) plasmid (Fermentas; St.
Leon-Rot, Germany). For digoxygenin (DIG)-labeling, 12
μl of linearized plasmid (EcoRI: anti-sense or BamHI:
sense) were combined with 2 μl 10-fold buffer (Roche;
Mannheim, Germany), 1 μl RNAsin, 2 μl T3 (for anti-
sense synthesis) or T7 (for sense synthesis) RNA polymer-
ase and 2 μl labeling mix containing 7.1 μl ATP, 7.1 μl
CTP, 7.1 μl GTP, 4.6 μl UTP, 20.5 μl RNase free water, and
25 μl DIG-11-UTP (Roche; Cat.-No.: 1209256) in order to
conduct in vitro transcription for 2 h (37°C). Afterwards,
the freshly prepared probe was diluted by adding 70 μl
RNase free water and 10 μl 0.1 M DTT. The embryos were
dissected in ice-cold PBS, followed by overnight fixation
in 4% PFA, 3 washes in PBS with 1% Tween 20 (PBT) for
5 minutes, and dehydration in rising methanol concentra-
tions. Next, specimens were rehydrated with decreasing
methanol concentrations. For increasing permeability and
signal detection, embryos were incubated in 6% H2O2 for
1 h and subsequently treated with proteinase K for 15 min
with 3 washing steps (5 min each) in PBT. Digestion wasBMC Developmental Biology 2009, 9:45 http://www.biomedcentral.com/1471-213X/9/45
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stopped in 2 mg/ml glycine in PBT for 20 min and 2 wash-
ing steps in PBT followed by post fixation in 4% PFA (in
PBT) for 20 min at room temperature. PFA was removed
by 3 washing steps in PBT. After incubation in hybridiza-
tion solution containing 50% deionized formamide, 5×
SSC [pH 4.5], 1% SDS, 50 μg/ml tRNA and 50 μg/ml
heparin at 65°C for 1 h, 1–2 μl denaturized DIG-labeled
probes (2 min at 90°C) were added and hybridized at
65°C overnight. Finally, embryos were washed 3 times for
1 h in solution I (50% formamide, 5 × SSC [pH 4.5], 1%
SDS) at 65°C followed by 3 washing steps for 1 hour in
solution II (50% formamide, 2 × SSC [pH 4.5], 1% Tween
20) at 60°C and washing 3 times in TBST for 5 min each.
Before the embryos were treated with anti-DIG antibody
(1:2000) in 1% sheep serum/TBST overnight at 4°C, we
conducted a blocking step in 10% heat-inactivated sheep
serum/TBST with 0.1% blocking reagent (Roche; Cat.-No.:
11112589001) for 1 h at room temperature. After per-
forming post-antibody washes (3 times 10 min and 5
times 1 h in TBST), samples were hybridized in fresh pre-
pared NTMT [pH 9.5] solution containing 100 mM NaCl,
100 mM Tris-Cl (pH 9.5), 50 mM MgCl2 and 0.1% Tween
20. For signal detection, NTMT solution was removed and
reaction mix (NTMT with 125 μg/ml BCIP and 250 μg/ml
NBT) was added. To stop the staining process, samples
were washed 3 times in PBT, followed by post-fixation in
4% PFA. The embryos were analyzed with a Leica MZ 9.5
stereo microscope (Wetzlar, Germany).
Preparation of cDNA
Mouse organs were immediately snap-frozen following
their collection from 3 sets of 6 animals of each age. Pri-
mary mouse brain cells from 3 independent preparations
of 3 pregnant animals or mouse organs were homoge-
nized in TRIzol reagent (Invitrogen), and the total RNA
was purified according the TRIzol protocol. RNA concen-
trations were determined by using a UV-Visible Spectro-
photometer (Biomate 3 spectrometer, Fisher Scientific,
Waltham, MA, USA). A High Capacity cDNA Reverse
Transcription kit (Applied Biosystems, Foster City, CA,
USA) was used to generate total cDNA for the real-time
PCR from 5 μg total RNA from each sample as per the
manufacturer's recommendations.
Real-time PCR (TaqMan)
TaqMan cDNA samples were prepared as described. 5'-
FAM-labeled probes and appropriate primer pairs for
detection of murine yy2 (probe: 6FAM-cagcctgttcttcagctat-
gggatcttctt-BBQ; primer: 5'-gggtgacaaacagtgggagc-3' (for-
ward) and 5'-ggatcagaaagatcaatgccaggt-3' (reverse)), yy1
(probe: 6FAM-agggtctgagaggtcaatgccaggt-BBQ; primer: 5'-
atgaaacagtggttgaagagcagatc-3' (forward) and 5'-caagctatt-
gttcttggagcatcatc-3'(reverse)) and mbtps2  (probe: 6FAM-
tgtcccgttactaatgtgcaagattggaa-BBQ; primer: 5'-ggagaccttgt-
cactcatctacagga-3' (forward) and 5'-gtcgtttgtatgctctaact-
gggaag-3' (reverse)) were designed and synthesized by TIB
MOLBIOL (Berlin, Germany). β-actin  (TaqMan Gene
Expression Assays; Cat.-No.: ACTB 4352664-0602004)
was purchased from Applied Biosystems. For all PCR reac-
tions, 1 μl of cDNA was added to 10 μl TaqMan 2× Uni-
versal PCR Mastermix Mix (Applied Biosystems), 1 μl of
each primer [20 μM], 1 μl 5'-FAM-labeled probe [0.3 μM]
and 8 μl deionized H2O. All reactions were performed in
duplicates and all three transcripts (within each set of
specimens) were always analyzed within the same experi-
ment. Amplification and fluorescence detection was con-
ducted with the i-Cycler Multicolor Real-Time PCR
Detection System (Bio-Rad; Munich, Germany). The fluo-
rescence threshold value was calculated by using the iCy-
cle iQ Optical System Software, version 3.1. yy2, yy1 and
mbtps2 values were normalized against β-actin.
Statistical analysis
Statistical significances were determined by using the one-
way analysis of variance (ANOVA). Bonferroni's multiple
comparison procedure was used to discriminate, which
means were different from others. A p-value < 0.05 was
considered to be significant.
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Additional file 1
Detection of yy2, mbtps2 and yy1 in primary cells. Expression of yy2, 
mbtps2 and yy1 in the primary cells (neurons, microglia and astrocytes) 
isolated from the murine brain were analyzed by conventional PCR (30 
cycles per reaction; yy2: 5'-accagcgtaggccaaaccatcgaagta-3' (forward) 
and 5'-cgtcaaaccacagagattcccttcata-3' (reverse); β-actin: 5'-actgctct-
ggctcctagcac-3' (forward) and 5'-acatctgctggaaggtggac-3' (reverse); 
mbtps2: 5'-ggagaccttgtcactcatctacagga-3' (forward) and 5'-gtcgtttgtat-
gctctaactgggaag-3' (reverse); yy1: 5'-atgaaacagtggttgaagagcagatc-3' (for-
ward) and 5'-caagctattgttcttggagcatcatc-3'(reverse)). While mbtps2 and 
yy1 are strongly and constantly expressed in all cell types, yy2 is reduced 
in neurons. Expression of β-actin served as internal control (multiplex 
PCR; upper panel). n = 3
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Additional file 2
Expression of yy2, mbtps2 and yy1 in testis, liver, kidney, thymus and 
spleen. Levels of yy2, mbtps2 and yy1 in the different stages of testis, 
liver, kidney and spleen development (E16, P10 and P30) were analyzed 
by conventional PCR (30 cycles per reaction;yy2: 5'-accagcgtaggccaaac-
catcgaagta-3' (forward) and 5'-cgtcaaaccacagagattcccttcata-3' (reverse); 
β-actin: 5'-actgctctggctcctagcac-3' (forward) and 5'-acatctgctggaaggt-
ggac-3' (reverse); mbtps2: 5'-ggagaccttgtcactcatctacagga-3' (forward) 
and 5'-gtcgtttgtatgctctaactgggaag-3' (reverse); yy1: 5'-atgaaacagtggtt-
gaagagcagatc-3' (forward) and 5'-caagctattgttcttggagcatcatc-
3'(reverse)). With the exception of thymus for yy2 and testis regarding 
mbtps2, both gene products are differentially regulated in all tested 
organs. However, yy1 expression only showed developmental changes in 
liver and spleen. Expression of β-actin served as internal control (multi-
plex PCR; upper panel). n = 3
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Additional file 3
Purity of primary cells. The Table shows the means of relative expression 
including standard deviation (SD) of specific marker genes as β3-tubulin 
(Tuj-1) for neurons, ionized calcium-binding adapter molecule-1 
(Iba-1) for microglia and glial fibrillary acidic protein (GFAP) for 
astrocytes related to β-actin (probes: Tuj-1 Cat.-No.: Mm00727586_s1; 
Iba-1 Cat.-No.: Mm00479862_g1; GFAP Cat.-No.: 
Mm00546086_m1; β-actin: Cat.-No.: 4352933E; Applied Biosystems) 
determined by real-time PCR.
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